Market Overview:
The global spinal cord trauma treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of spinal cord injuries, rising awareness about available treatments, and technological advancements in spinal cord injury treatment. The global spinal cord trauma treatment market is segmented on the basis of type into complete spinal cord injuries and partial spinal cord injuries. The complete spine injury segment is further sub-segmented into primary damage and secondary damage segments. On the basis of application, the market is segmented into hospitals and trauma centers. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Some key players operating in this market are Medtronic plc., Stryker Corporation., Boston Scientific Corporation., Johnson & Johnson Services Inc., Zimmer Biomet Holdings Inc., NuVasive Inc.
Product Definition:
The spinal cord is a bundle of nerves that runs down the back. It carries messages between the brain and the rest of the body. Spinal cord trauma is damage to these nerves. This can cause problems with movement, feeling, and bowel and bladder control. Treatment for spinal cord trauma includes medicines, surgery, physical therapy, and rehabilitation.
Complete Spinal Cord Injuries:
Complete Spinal Cord Injuries (CSCI) is a rare condition that affects the spinal cord. It causes severe and permanent impairment of body functions such as movement, feeling, and sensation. CSCIs are classified into two types: Acute complete spinal cord injuries (ACS) & chronic complete spinal cord injuries (CCS).
According to the National Spinal Cord Injury Statistical Center, in U.S.
Partial Spinal Cord Injuries:
Partial spinal cord injuries (PSCI) are localized damage to the spinal cord. The partial injury is caused by a blow or fall that does not penetrate the vertebrae and cause compression of the Cord nerves. PSCI can be classified into three types: Lateral PSCI, Mid-thoracic PSCI, and Central thoracic PSCI.
Application Insights:
The hospitals segment dominated the global spinal cord trauma treatment market in 2017 owing to factors such as availability of advanced healthcare facilities and highly skilled staff. Hospitals are equipped with the most sophisticated technologies for diagnosing and treating spinal cord injuries. These hospitals have a dedicated wing or floor for patients suffering from spinal cord injuries, thereby ensuring high-quality care.
Trauma centers segment is expected to grow at a lucrative rate over the forecast period due to increasing number of TTI cases across the globe. According to WHO, around 50% of all severe traumatic brain injury (TBI) cases occur in low-and middle-income countries worldwide, which indicates that majority of TBIs go unrecognized and underreported globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-developed healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region as compared to other regions. In addition, a rise in road accidents and sports injuries is also expected to propel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing government initiatives for trauma care facilities along with growing medical tourism industry supported by low procedural costs and affordable treatment options offered by countries such as India and China. Moreover, Japan has one of the highest incidence rates of SCI due largely its aging population combined with an increase in prevalence rate associated with osteoporosis which are factors that need immediate attention for proper management of spinal cord injuries cases resulting into increased demand for surgical procedures related thereto thereby driving regional growth during the estimated time span.
Growth Factors:
- Increasing incidence of spinal cord injuries: The increasing incidence of spinal cord injuries is one of the key growth drivers for the global spinal cord trauma treatment market. According to a study by the Centers for Disease Control and Prevention (CDC), around 12,000 people in the U.S. sustain a new spinal cord injury each year. This number is expected to rise in future due to increasing awareness about spine health and rising prevalence of road accidents and sports-related injuries.
- Growing demand for minimally invasive treatments: The growing demand for minimally invasive treatments is another major growth driver for the global spinal cord trauma treatment market. Minimally invasive techniques are less traumatic and cause less pain than traditional open surgery procedures, resulting in shorter hospital stays and faster recovery times. This has led to an increase in their adoption over traditional surgical procedures, especially among patients who are apprehensive about undergoing surgery or those with complex medical conditions that require longer hospital stays post-surgery .
Scope Of The Report
Report Attributes
Report Details
Report Title
Spinal Cord Trauma Treatment Market Research Report
By Type
Complete Spinal Cord Injuries, Partial Spinal Cord Injuries
By Application
Hospitals, Trauma Centers
By Companies
Acorda Therapeutics, Inc. , Asterias Biotherapeutics , ReNetX Bio. , BioArctic AB , BioTime, Inc. , InVivo Therapeutics , Kringle Pharma, Inc. , Novartis AG , Pfizer Inc. , Pharmicell Co. Ltd. , Vertex Pharmaceuticals Inc. , Bioaxone Biosciences, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Spinal Cord Trauma Treatment Market Report Segments:
The global Spinal Cord Trauma Treatment market is segmented on the basis of:
Types
Complete Spinal Cord Injuries, Partial Spinal Cord Injuries
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Trauma Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acorda Therapeutics, Inc.
- Asterias Biotherapeutics
- ReNetX Bio.
- BioArctic AB
- BioTime, Inc.
- InVivo Therapeutics
- Kringle Pharma, Inc.
- Novartis AG
- Pfizer Inc.
- Pharmicell Co. Ltd.
- Vertex Pharmaceuticals Inc.
- Bioaxone Biosciences, Inc.
Highlights of The Spinal Cord Trauma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Complete Spinal Cord Injuries
- Partial Spinal Cord Injuries
- By Application:
- Hospitals
- Trauma Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spinal Cord Trauma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spinal cord trauma treatment is the medical care and rehabilitation necessary to help a person who has suffered spinal cord injury regain function. Treatment may include physical therapy, occupational therapy, speech therapy, and psychological counseling.
Some of the major players in the spinal cord trauma treatment market are Acorda Therapeutics, Inc. , Asterias Biotherapeutics , ReNetX Bio. , BioArctic AB , BioTime, Inc. , InVivo Therapeutics , Kringle Pharma, Inc. , Novartis AG , Pfizer Inc. , Pharmicell Co. Ltd. , Vertex Pharmaceuticals Inc. , Bioaxone Biosciences, Inc..
The spinal cord trauma treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spinal Cord Trauma Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Spinal Cord Trauma Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Spinal Cord Trauma Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Spinal Cord Trauma Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Spinal Cord Trauma Treatment Market Size & Forecast, 2018-2028
4.5.1 Spinal Cord Trauma Treatment Market Size and Y-o-Y Growth
4.5.2 Spinal Cord Trauma Treatment Market Absolute $ Opportunity
Chapter 5 Global Spinal Cord Trauma Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Spinal Cord Trauma Treatment Market Size Forecast by Type
5.2.1 Complete Spinal Cord Injuries
5.2.2 Partial Spinal Cord Injuries
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Spinal Cord Trauma Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Spinal Cord Trauma Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Trauma Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Spinal Cord Trauma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Spinal Cord Trauma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Spinal Cord Trauma Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Spinal Cord Trauma Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Spinal Cord Trauma Treatment Market Size Forecast by Type
9.6.1 Complete Spinal Cord Injuries
9.6.2 Partial Spinal Cord Injuries
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Spinal Cord Trauma Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Trauma Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Spinal Cord Trauma Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Spinal Cord Trauma Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Spinal Cord Trauma Treatment Market Size Forecast by Type
10.6.1 Complete Spinal Cord Injuries
10.6.2 Partial Spinal Cord Injuries
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Spinal Cord Trauma Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Trauma Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Spinal Cord Trauma Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Spinal Cord Trauma Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Spinal Cord Trauma Treatment Market Size Forecast by Type
11.6.1 Complete Spinal Cord Injuries
11.6.2 Partial Spinal Cord Injuries
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Spinal Cord Trauma Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Trauma Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Spinal Cord Trauma Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Spinal Cord Trauma Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Spinal Cord Trauma Treatment Market Size Forecast by Type
12.6.1 Complete Spinal Cord Injuries
12.6.2 Partial Spinal Cord Injuries
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Spinal Cord Trauma Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Trauma Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Spinal Cord Trauma Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Spinal Cord Trauma Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Spinal Cord Trauma Treatment Market Size Forecast by Type
13.6.1 Complete Spinal Cord Injuries
13.6.2 Partial Spinal Cord Injuries
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Spinal Cord Trauma Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Trauma Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Spinal Cord Trauma Treatment Market: Competitive Dashboard
14.2 Global Spinal Cord Trauma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Acorda Therapeutics, Inc.
14.3.2 Asterias Biotherapeutics
14.3.3 ReNetX Bio.
14.3.4 BioArctic AB
14.3.5 BioTime, Inc.
14.3.6 InVivo Therapeutics
14.3.7 Kringle Pharma, Inc.
14.3.8 Novartis AG
14.3.9 Pfizer Inc.
14.3.10 Pharmicell Co. Ltd.
14.3.11 Vertex Pharmaceuticals Inc.
14.3.12 Bioaxone Biosciences, Inc.
